High Tower Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $158,460 - $232,217	-6,219 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$32.46 - $43.42 $908 - $1,215	28 Added 0.45%	6,219 $220,000
Q1 2021 May 10, 2021	BUY	$38.94 - $50.85 $25,349 - $33,103	651 Added 11.75%	6,191 $250,000
Q4 2020 Feb 10, 2021	BUY	$37.65 - $63.77 $208,581 - $353,285	5,540 New	5,540 $237,000
Q1 2020 May 21, 2020	SELL	$41.72 - $87.2 $188,699 - $394,405	-4,523 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $206,701 - $370,252	4,523 New	4,523 $361,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.